MB, Levis & Associates’s iShares iBonds Dec 2030 Term Corporate ETF IBDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-603,760
Closed -$13.3M – 274
2025
Q2
$13.3M Buy
603,760
+9,890
+2% +$214K 5.83% 7
2025
Q1
$12.9M Buy
593,870
+3,912
+0.7% +$84.1K 5.99% 7
2024
Q4
$12.6M Buy
589,958
+8,010
+1% +$173K 6.31% 6
2024
Q3
$12.9M Buy
581,948
+8,299
+1% +$181K 6.36% 6
2024
Q2
$12.2M Buy
573,649
+14,432
+3% +$305K 6.41% 6
2024
Q1
$12M Buy
559,217
+12,153
+2% +$260K 6.43% 6
2023
Q4
$11.8M Buy
547,064
+27,124
+5% +$561K 6.77% 6
2023
Q3
$10.6M Buy
519,940
+5,043
+1% +$105K 6.87% 6
2023
Q2
$10.9M Buy
514,897
+79,850
+18% +$1.7M 6.99% 5
2023
Q1
$9.37M Buy
435,047
+40,350
+10% +$858K 6.52% 5
2022
Q4
$8.21M Buy
+394,697
New +$8.14M 6.42% 5

Other funds holding IBDV

MB, Levis & Associates's IBDV Position: Q3 2025 in Review

MB, Levis & Associates sold out of iShares iBonds Dec 2030 Term Corporate ETF (IBDV) in Q3 2025, closing a stake of 603,760 shares — an estimated $13.3M sold.

MB, Levis & Associates first reported a position in IBDV in Q4 2022 and held it in 11 quarters. The position peaked at $13.3M in Q2 2025. 271 funds tracked by Wall St. Rank hold IBDV as of Q3 2025.

  • MB, Levis & Associates reported no remaining iShares iBonds Dec 2030 Term Corporate ETF position as of Q3 2025 after selling out during the quarter.
  • MB, Levis & Associates sold 603,760 iShares iBonds Dec 2030 Term Corporate ETF shares in Q3 2025, an estimated $13.3M.
  • MB, Levis & Associates first reported a position in iShares iBonds Dec 2030 Term Corporate ETF in Q4 2022 and held it in 11 quarters.
  • MB, Levis & Associates's iShares iBonds Dec 2030 Term Corporate ETF position peaked at $13.3M in Q2 2025.
  • 271 funds tracked by Wall St. Rank held iShares iBonds Dec 2030 Term Corporate ETF as of Q3 2025.

Based on MB, Levis & Associates's 13F filing for Q3 2025, filed 15 Oct 2025.